I believe we are waiting for some new evidence that
I believe we are waiting for some new evidence that supports all the previous peace meal data, that can clearly stand on it's own.
Good progress takes time and usually takes making changes as we move forward, which we have clearly seen with Leronlimab. The end is near for sure. We are close to proving we can treat our indication.
We now have the indication, but we still need to prove it, which could be as early as 6 months or maybe a year at most (for initial large scale data review).
Maybe we will get a partial commitment from someone between then and now, but it would only happen if we need the funds to continue going forward. I just don't think management is ready to give any future profit margin to anyone just yet in return for funding to keep us going. That would not be in our best interest and would only result in a small rise in share price.
I don't think any partner will commit large sums of capital until they feel highly certain that they would get an FDA approval and that there is a market for the indication that we are advertising.
Lots of things simmering for sure and I think we should be hearing about forward progress on several of those items soon. I'm happy to just not have negative news about something we are doing.
There is way too much evil in the BIO-Pharma Industry (evil empire) and I'm sick and tired of seeing us be the victims, and yes, I do believe somebody pulled some strings to get us put on a hold. So don't let anyone know we have the achieved the success we need until we actually achieve it.
Until we have irrefutable evidence that meets the basic minimum industry/FDA standard, we should not be giving shorts, day-traders, and the evil empire any news that can be used to cause us harm.
I'll just buy more if CYDY goes on sale. I've already increased my initial investment by 20x so lets do 40x (lol). I can wait 12 more months or longer if necessary. If you're staring at the share price all the time, you might as well keep buying. At least you'll get a little bit more satisfaction. At least I do.
16
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Proactive Eye Care: The New Frontier Today's eye care landscape is all about catching things early, folks. Long gone are the days of waiting for eyesight to deteriorate before rushing to the nearest eye doc. In Racine, interventional ophthalmology is shifting gears towards preventive care—looking ahead to stop eye diseases in their tracks before they muck up a person's...
Continue Reading
Transforming Urgent Gift-Giving with Local Delivery Ever found yourself scrambling for a last-minute gift when time seems to be slipping away? That's where DoorDash steps up, changing the game with their same-day delivery options. In the fast-paced world we're living in, folks aren't just leaning on DoorDash for takeout anymore. They're pushing it as a lifeline for...
Continue Reading
Intellectia.AI Sparks New Trading Era Intellectia.AI, from the bustling streets of New York, is cutting through the noise with a flashy update to its AI-powered trading setup. They've thrown a heap of new toys into the ring, letting folks piggyback on high-grade stock moves in the blink of an eye. Gone are the days of fumbling with cumbersome data and execution. Breaking...
Continue Reading
Seismic Merger: Reliable Sprinkler and ASC Join Forces When two companies with roots stretching back to the 1800s decide to merge, it's not just a business move—it's a bold statement. Reliable Automatic Sprinkler and ASC Engineered Solutions, with over 175 years of combined innovation, have officially become Reliable Safety & Flow Corporation. This ain't just a...
Continue Reading
High Stakes and Huge Paydays: The Venom Breakdown Alright, folks, here's a tale of how the cards fell in one of the most electrifying poker standoffs at Americas Cardroom. With prize pools clocking in at a staggering $15.095 million, the Dual Mystery Bounty Venoms really stacked the chips high. From the gritty, bustling halls of the internet to the proverbial green-felt...
Continue Reading
Hims Faces Harsh Lessons With FTC Lawsuit There's trouble brewing in the world of telehealth, and Hims & Hers Health (NYSE: HIMS) is right at the eye of the storm. They've gone from a darling of digital health to a pariah faster than you can say 'data breach.' On July 29, 2026, they took a hit so hard you’d think the company stepped into the ring with a heavyweight...
Continue Reading
A Leap Forward in Cancer Care: Proton Therapy Revolution Dang, just when you think you've heard it all in cancer treatment, Fortis Healthcare drops a bombshell: India’s first upright proton therapy system. Boom! This isn't your run-of-the-mill radiation treatment we're talking about here. This is the futuristic flair of the MEVION S250-FIT™, featuring upright...
Continue Reading
Jollibee Partners with DreamWorks Animation Never thought I’d see the day: Jollibee, that familiar face of fast food, teaming up with the creative juggernaut DreamWorks Animation. They’re calling it a celebration of friendship and Filipino culture, wrapped up neatly in the context of a flick called Forgotten Island. Set to sizzle in theaters on September 25, 2026,...
Continue Reading
The Plot Thickens with Innventure's DarkNX Project Buckle up, fellow market sling-riders; the Innventure tale is a rocky one for the books. Imagine this: You’ve plunked down your hard-earned cash on Innventure Inc. (NASDAQ: INV), lured by their glowing pronouncements about a supposed golden egg project, the Accelsius DarkNX data-center deal. A big talk about...
Continue Reading
Glass & Vinyl Ambitions: A New Chapter Who would have guessed? The seasoned window maker Showcase Window and Door Company is putting its prime manufacturing facility up for grabs. The online auction, orchestrated by Tiger Group, kicks off September 10, and it's sure to stir up some excitement in the industry. With picking up operations now within reach, it feels like...
Continue Reading
Top 5 Most Recently Viewed Articles
Innovative Solar Energy Collector Blends with Nature's Beauty An inventor hailing from West Delray Beach, Florida, has created a groundbreaking solar energy collector known as the SILENT ENERGY SOLAR TREE. This innovative design aims to enhance the visual appeal of solar energy systems while improving their efficiency and effectiveness in capturing solar power. The...
Continue Reading
Understanding the Riksbank Certificate Auction The recent auction conducted by the Riksbank has unveiled some compelling figures that reflect the current market dynamics. Investors closely monitoring these developments can gain significant insights into the monetary policies shaping Sweden's economic landscape. Details of the Auction Process The results from the recent...
Continue Reading
Understanding Apple's Current Market Position The global smartphone market reveals enthralling narratives of competition and adaptation. At one extreme, we have the colossal Apple Inc. (NASDAQ: AAPL), which faces significant challenges operating in China. Conversely, we see Transsion Holdings, a company largely unknown in Western markets, successfully navigating the...
Continue Reading
Sempra Board Approves Quarterly Dividend for Shareholders Sempra (NYSE: SRE) has officially recognized its commitment to its shareholders by declaring a quarterly dividend of $0.62 per share on the company's common stock. This decision reflects the company's ongoing dedication to delivering value to its investors, demonstrated through consistent dividend payments. Details...
Continue Reading
Greenland Advanced Oral Care Welcomes Dr. Eryn Huber In a significant move to strengthen its team, Greenland Advanced Oral Care proudly announces the addition of Dr. Eryn Huber to its expert dental staff. This development underscores the practice's commitment to providing top-notch, personalized oral care. Dr. Eryn Huber's Background Dr. Eryn Huber comes with over ten...
Continue Reading